BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 34668119)

  • 1. Clinical Outcomes of Taiwanese Patients with Resected Oral Cavity Squamous Cell Carcinoma Who Underwent Reconstruction with Free Versus Local Flaps.
    Liao CT; Wen YW; Lee SR; Ng SH; Liu TW; Tsai ST; Tsai MH; Lin JC; Chien CY; Lou PJ; Wang CP; Chu PY; Leu YS; Tsai KY; Terng SD; Chen TM; Wang CH; Chen WC; Lee LY; Lin CY; Wang HM; Fang TJ; Huang SF; Kang CJ; Chang KP; Yen TC; Yang LY; Lin CH;
    Ann Surg Oncol; 2022 Feb; 29(2):1130-1140. PubMed ID: 34668119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of survival in advanced oral cancers after salvage surgery with free tissue flap reconstruction.
    Hafström A; Wahlberg P; Klasson S; Greiff L; Sjövall J
    Eur Arch Otorhinolaryngol; 2023 Jun; 280(6):2953-2964. PubMed ID: 36897366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Should sub-millimeter margins be deemed positive in oral cavity squamous cell carcinoma?
    Kang CJ; Lee LY; Ng SH; Lin CY; Fan KH; Chen WC; Lin JC; Tsai YT; Lee SR; Chien CY; Hua CH; Ping Wang C; Chen TM; Terng SD; Tsai CY; Wang HM; Hsieh CH; Yeh CH; Lin CH; Tsao CK; Cheng NM; Fang TJ; Huang SF; Lee LA; Fang KH; Wang YC; Lin WN; Hsin LJ; Yen TC; Wen YW; Liao CT
    Oral Oncol; 2024 Apr; 151():106745. PubMed ID: 38460286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognostic value of extranodal extension in human papillomavirus-associated oropharyngeal squamous cell carcinoma.
    An Y; Park HS; Kelly JR; Stahl JM; Yarbrough WG; Burtness BA; Contessa JN; Decker RH; Koshy M; Husain ZA
    Cancer; 2017 Jul; 123(14):2762-2772. PubMed ID: 28323338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early relapse is an adverse prognostic factor for survival outcomes in patients with oral cavity squamous cell carcinoma: results from a nationwide registry study.
    Tsai CY; Wen YW; Lee SR; Ng SH; Kang CJ; Lee LY; Hsueh C; Lin CY; Fan KH; Wang HM; Hsieh CH; Yeh CH; Lin CH; Tsao CK; Fang TJ; Huang SF; Lee LA; Fang KH; Wang YC; Lin WN; Hsin LJ; Yen TC; Cheng NM; Liao CT
    BMC Cancer; 2023 Feb; 23(1):126. PubMed ID: 36750965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical outcomes of patients with pT4a and pT4b oral cavity squamous cell carcinoma who had undergone surgery: Results from a Taiwanese registry-based, nationwide cohort study.
    Kang CJ; Wen YW; Lee SR; Ng SH; Lee LA; Lee LY; Hsueh C; Lin CY; Fan KH; Wang HM; Hsieh CH; Yeh CH; Tsai CY; Lin CH; Tsao CK; Fang TJ; Huang SF; Fang KH; Wang YC; Lin WN; Hsin LJ; Yen TC; Cheng NM; Liao CT
    Oral Oncol; 2022 Mar; 126():105750. PubMed ID: 35123256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Surgical Margin Distance With Survival in Patients With Resected Head and Neck Squamous Cell Carcinoma: A Secondary Analysis of a Randomized Clinical Trial.
    Sunkara PR; Graff JT; Cramer JD
    JAMA Otolaryngol Head Neck Surg; 2023 Apr; 149(4):317-326. PubMed ID: 36821132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparing the clinical outcomes of initial surgery and primary definitive radiotherapy with a dosage of 6600 cGy or higher in cT1-2N0M0 oral cavity squamous cell carcinoma: A nationwide cohort study.
    Lin CY; Chen WC; Wen YW; Fan KH; Lin JC; Ng SH; Tsai YT; Lee SR; Kang CJ; Lee LY; Chien CY; Hua CH; Wang CP; Chen TM; Terng SD; Tsai CY; Wang HM; Hsieh CH; Yeh CH; Lin CH; Tsao CK; Cheng NM; Fang TJ; Huang SF; Lee LA; Fang KH; Wang YC; Lin WN; Hsin LJ; Yen TC; Liao CT
    Cancer Med; 2024 May; 13(10):e7127. PubMed ID: 38770540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimizing margin status for improving prognosis in patients with oral cavity squamous cell carcinoma: A retrospective study from the two highest-volume Taiwanese hospitals.
    Liao CT; Lee LY; Lee SR; Ng SH; Liu TW; Chien CY; Lin JC; Wang CP; Terng SD; Hua CH; Chen TM; Chen WC; Tsai YT; Kang CJ; Tsai CY; Chu YH; Lin CY; Fan KH; Wang HM; Hsieh CH; Yeh CH; Lin CH; Tsao CK; Yen TC; Cheng NM; Fang TJ; Huang SF; Lee LA; Fang KH; Wang YC; Lin WN; Hsin LJ; Wen YW
    Front Oncol; 2022; 12():1019555. PubMed ID: 36452510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathological risk factors stratification in pN3b oral cavity squamous cell carcinoma: Focus on the number of positive nodes and extranodal extension.
    Liao CT; Lee LY; Hsueh C; Lin CY; Fan KH; Wang HM; Hsieh CH; Ng SH; Lin CH; Tsao CK; Kang CJ; Fang TJ; Huang SF; Chang KP; Yang LY; Yen TC
    Oral Oncol; 2018 Nov; 86():188-194. PubMed ID: 30409299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. cN+pN0 disease does not portend a less favorable prognosis compared with cN0pN0 in patients with resected oral cavity squamous cell carcinoma.
    Lin CY; Lee LY; Cheng NM; Lee SR; Tsai CY; Hsueh C; Fan KH; Wang HM; Hsieh CH; Ng SH; Yeh CH; Lin CH; Tsao CK; Fang TJ; Huang SF; Lee LA; Kang CJ; Fang KH; Wang YC; Lin WN; Hsin LJ; Yen TC; Liao CT
    Cancer Med; 2021 Oct; 10(20):6947-6958. PubMed ID: 34558224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poor tumor differentiation is an independent adverse prognostic variable in patients with locally advanced oral cavity cancer--Comparison with pathological risk factors according to the NCCN guidelines.
    Lee LY; Lin CY; Cheng NM; Tsai CY; Hsueh C; Fan KH; Wang HM; Hsieh CH; Ng SH; Yeh CH; Lin CH; Tsao CK; Fang TJ; Huang SF; Lee LA; Kang CJ; Fang KH; Wang YC; Lin WN; Hsin LJ; Yen TC; Liao CT
    Cancer Med; 2021 Oct; 10(19):6627-6641. PubMed ID: 34533269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of reconstruction on positive margin rates in oral cancer: Using length of stay as a proxy measure for flap reconstruction in a national database.
    Campbell DA; Pipkorn P; Divi V; Stadler M; Massey B; Campbell B; Richmon JD; Graboyes E; Puram S; Zenga J
    Am J Otolaryngol; 2021; 42(5):103012. PubMed ID: 33857781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of royal college of pathologists and college of american pathologists definition for positive margins in oral cavity squamous cell carcinoma.
    Brinkman D; Callanan D; Jawad H; O'Sullivan R; O'Shea R; Dias A; Feeley L; Sheahan P
    Oral Oncol; 2022 Apr; 127():105797. PubMed ID: 35272227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extranodal extension in resected oral cavity squamous cell carcinoma: more to it than meets the eye.
    Agarwal JP; Kane S; Ghosh-Laskar S; Pilar A; Manik V; Oza N; Wagle P; Gupta T; Budrukkar A; Murthy V; Swain M
    Laryngoscope; 2019 May; 129(5):1130-1136. PubMed ID: 30421434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant therapy improves survival in pT4aN0 oral cavity squamous cell carcinoma with bone invasion.
    Stanford-Moore GB; Sola AM; Chan J; El-Sayed I; George J; Ha P; Ryan WR; Heaton CM
    Am J Otolaryngol; 2022; 43(2):103303. PubMed ID: 34894450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perioperative Risk Factors Associated With Unplanned Reoperation Following Vascularized Free Flaps Reconstruction of the Oral Squamous Cell Carcinoma.
    Fu G; Wang C; Zeng C; Liu Z; Han Z; Huang H; Cao M
    J Craniofac Surg; 2022 Nov-Dec 01; 33(8):2507-2512. PubMed ID: 36409870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of microscopic versus macroscopic extranodal extension in oral cavity squamous cell carcinoma: National cancer database analysis and review of the literature.
    Quinton BA; Cabrera CI; Tamaki A; Li S; Fowler N; Rezaee R; Lavertu P; Teknos T; Pan Q; Thuener J
    Am J Otolaryngol; 2022; 43(4):103511. PubMed ID: 35609426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcomes of Taiwanese patients with resected squamous cell carcinoma of the upper and lower gum.
    Tsai CY; Lee SR; Lee LY; Hsueh C; Lin CY; Fan KH; Wang HM; Hsieh CH; Ng SH; Yeh CH; Lin CH; Tsao CK; Fang TJ; Huang SF; Lee LA; Kang CJ; Fang KH; Wang YC; Lin WN; Hsin LJ; Yen TC; Cheng NM; Wen YW; Liao CT
    Oral Oncol; 2021 Jul; 118():105334. PubMed ID: 34020150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival benefit of post-operative chemotherapy for intermediate-risk advanced stage head and neck cancer differs with patient age.
    Chen MM; Colevas AD; Megwalu U; Divi V
    Oral Oncol; 2018 Sep; 84():71-75. PubMed ID: 30115479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.